{
  "id": "73bd23e3681533d0",
  "title": "STAT+: Pharmalittle: We\u2019re reading about Novo Nordisk suing Hims & Hers, deals by Lilly and Takeda, and more",
  "description": "Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned&#8230;",
  "content": "Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned&#8230;",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/09/novo-hims-obesity-patents-compounding-lilly-takeda/?utm_campaign=rss",
  "published_at": "2026-02-09T14:36:11+00:00",
  "fetched_at": "2026-02-10T00:34:54.529614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about Novo Nordisk suing Hims & Hers, deals by Lilly and Takeda, and more",
    "description": "Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned&#8230;",
    "url": "https://www.statnews.com/pharmalot/2026/02/09/novo-hims-obesity-patents-compounding-lilly-takeda/?utm_campaign=rss",
    "published": "2026-02-09T14:36:11+00:00",
    "source": "STAT"
  }
}